Sensus Healthcare Analyst Ratings
Sensus Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 158.06% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 05/04/2023 | 222.58% | HC Wainwright & Co. | $16 → $10 | Reiterates | → Buy |
| 05/04/2023 | 125.81% | Alliance Global Partners | $14.5 → $7 | Maintains | Buy |
| 02/10/2023 | 416.13% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 02/10/2023 | 367.74% | Alliance Global Partners | $16.5 → $14.5 | Maintains | Buy |
| 11/04/2022 | 432.26% | Alliance Global Partners | $17.5 → $16.5 | Maintains | Buy |
| 05/06/2022 | 416.13% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy |
| 03/03/2022 | 319.35% | HC Wainwright & Co. | $12 → $13 | Maintains | Buy |
| 02/14/2022 | 287.1% | HC Wainwright & Co. | $10 → $12 | Maintains | Buy |
| 12/02/2021 | 222.58% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 11/05/2021 | 190.32% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/06/2021 | 125.81% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/01/2021 | 93.55% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 02/26/2021 | 93.55% | Roth Capital | $4 → $6 | Maintains | Buy |
| 11/09/2020 | 29.03% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 05/11/2020 | -3.23% | B. Riley Securities | $5.5 → $3 | Maintains | Neutral |
| 05/08/2020 | 61.29% | HC Wainwright & Co. | $8 → $5 | Reiterates | → Buy |
| 11/07/2019 | 77.42% | B. Riley Securities | $14 → $5.5 | Downgrades | Buy → Neutral |
| 09/19/2018 | 222.58% | Maxim Group | $9 → $10 | Maintains | Buy |
| 08/27/2018 | 351.61% | HC Wainwright & Co. | → $14 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/07/2023 | 158.06% | HC Wainwright & Co. | 10 美元 → 8 美元 | 維護 | 購買 |
| 05/04/2023 | 222.58% | HC Wainwright & Co. | 16 美元 → 10 美元 | 重申 | → 購買 |
| 05/04/2023 | 125.81% | 聯盟全球合作伙伴 | 14.5 美元 → 7 美元 | 維護 | 購買 |
| 02/10/2023 | 416.13% | HC Wainwright & Co. | → 16 美元 | 重申 | → 購買 |
| 02/10/2023 | 367.74% | 聯盟全球合作伙伴 | 16.5 美元 → 14.5 美元 | 維護 | 購買 |
| 2022 年 4 月 11 日 | 432.26% | 聯盟全球合作伙伴 | 17.5 美元 → 16.5 美元 | 維護 | 購買 |
| 2022 年 6 月 5 日 | 416.13% | HC Wainwright & Co. | 13 美元 → 16 美元 | 維護 | 購買 |
| 2022 年 3 月 3 日 | 319.35% | HC Wainwright & Co. | 12 美元 → 13 美元 | 維護 | 購買 |
| 02/14/2022 | 287.1% | HC Wainwright & Co. | 10 美元 → 12 美元 | 維護 | 購買 |
| 2021 年 2 月 12 日 | 222.58% | HC Wainwright & Co. | 9 美元 → 10 美元 | 維護 | 購買 |
| 2021 年 5 月 11 日 | 190.32% | HC Wainwright & Co. | 7 美元 → 9 美元 | 維護 | 購買 |
| 2021 年 6 月 8 日 | 125.81% | HC Wainwright & Co. | 6 美元 → 7 美元 | 維護 | 購買 |
| 2021 年 1 月 3 日 | 93.55% | HC Wainwright & Co. | 4 美元 → 6 美元 | 維護 | 購買 |
| 2021 年 2 月 26 日 | 93.55% | 羅斯資本 | 4 美元 → 6 美元 | 維護 | 購買 |
| 2020 年 9 月 11 日 | 29.03% | HC Wainwright & Co. | 5 美元 → 4 美元 | 維護 | 購買 |
| 05/11/2020 | -3.23% | B. 萊利證券 | 5.5 美元 → 3 美元 | 維護 | 中立 |
| 05/08/2020 | 61.29% | HC Wainwright & Co. | 8 美元 → 5 美元 | 重申 | → 購買 |
| 11/07/2019 | 77.42% | B. 萊利證券 | 14 美元 → 5.5 美元 | 降級 | 買入 → 中性 |
| 09/19/2018 | 222.58% | Maxim 集團 | 9 美元 → 10 美元 | 維護 | 購買 |
| 08/27/2018 | 351.61% | HC Wainwright & Co. | → 14 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Sensus Healthcare (SRTS)?
Sensus Healthcare (SRTS) 的目標價格是多少？
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $8.00 expecting SRTS to rise to within 12 months (a possible 158.06% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月7日公佈了Sensus Healthcare（納斯達克股票代碼：SRTS）的最新目標股價。這家分析公司將目標股價定爲8.00美元，預計SRTS將在12個月內升至12個月內（可能上漲158.06％）。去年有6家分析公司公佈了評級。
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
分析師對Sensus Healthcare（SRTS）的最新評級是多少？
The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by HC Wainwright & Co., and Sensus Healthcare maintained their buy rating.
Sensus Healthcare（納斯達克股票代碼：SRTS）的最新分析師評級由HC Wainwright & Co. 提供，Sensus Healthcare 維持買入評級。
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
Sensus Healthcare（SRTS）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Sensus Healthcare的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Sensus Healthcare的最後一次評級是在2023年8月7日提交的，因此您應該預計下一個評級將在2024年8月7日左右公佈。
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
分析師對 Sensus Healthcare (SRTS) 的評級正確嗎
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a maintained with a price target of $10.00 to $8.00. The current price Sensus Healthcare (SRTS) is trading at is $3.10, which is out of the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Sensus Healthcare（SRTS）評級維持不變，目標股價爲10.00美元至8.00美元。Sensus Healthcare（SRTS）目前的交易價格爲3.10美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。